Stefan Ryser

2009

In 2009, Stefan Ryser earned a total compensation of $392.5K as Former Senior Vice President, Corporate Strategy at MabVax Therapeutics Holdings, a 7% increase compared to previous year.

Compensation breakdown

Salary$189,583
Other$202,922
Total$392,505

Ryser received $202.9K in other compensation, accounting for 52% of the total pay in 2009.

Ryser also received $189.6K in salary.

Rankings

In 2009, Stefan Ryser's compensation ranked 7,618th out of 9,885 executives tracked by ExecPay. In other words, Ryser earned more than 22.9% of executives.

ClassificationRankingPercentile
All
7,618
out of 9,885
23rd
Division
Manufacturing
2,844
out of 3,690
23rd
Major group
Chemicals And Allied Products
649
out of 871
26th
Industry group
Drugs
465
out of 643
28th
Industry
Pharmaceutical Preparations
341
out of 446
24th
Source: SEC filing on April 7, 2010.

Ryser's colleagues

We found four more compensation records of executives who worked with Stefan Ryser at MabVax Therapeutics Holdings in 2009.

2009

Michael Wick

MabVax Therapeutics Holdings

Chief Executive Officer

2009

Cynthia Butitta

MabVax Therapeutics Holdings

Chief Financial Officer

2009

Marc Steuer

MabVax Therapeutics Holdings

Senior Vice President, Business Development

2009

William Kaplan

MabVax Therapeutics Holdings

General Counsel

You may also like